Sector Silence Therapeutics plc

Aandelen

SLN

US82686Q1013

Biotechnologie & Medisch Onderzoek

Beurs gesloten - Nasdaq 22:00:00 05-12-2025 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
6,960 USD -2,38% Intraday-grafiek van Silence Therapeutics plc +1,75% +1,16%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-2,38%+1,75%+6,91%+33,08%+1,16%-16,14%-59,06%-59,65% - 337 mln.
-0,95%-0,66%+0,59%-6,05%+1,38%+2,80%+7,78%-0,15%+245,99% 48,03 mld.
+0,41%-2,57%+7,06%+22,69%+14,93%+11,16%+3,73%+32,38%+232,03% 38,3 mld.
-2,56%-5,21%+4,43%+1,31%+74,81%+62,19%+59,96%+44,88% - 36,67 mld.
+0,38%-1,03%+3,97%+7,70%+1,67%+9,38%+19,64%-43,01%+195,13% 27,13 mld.
+0,61%-9,64%-7,81%+13,64%+64,98%+58,27%+162,26%+298,95% - 15,35 mld.
+1,48%+2,66%+35,97%+104,47%+82,08%+65,06%+211,95%+96,54% - 15,17 mld.
+0,05%+1,21%+14,06%+5,39%-11,37%-13,35%-12,77%-7,30%+152,13% 14,19 mld.
+0,43%-0,71%-9,27%-1,87%+127,07%+32,20% - - - 13,58 mld.
-0,16%-1,23%+12,07%+37,62%+133,64%+119,87%+102,58%+59,47%+37,02% 13,25 mld.
-1,51%-2,18%-1,34%+3,69%+49,23%+56,81%+63,84%+23,12%+1.071,93% 12,74 mld.
-0,37%-0,71%-1,67%-6,31%+19,29%+26,20%-14,46%-6,58%+70,86% 12,2 mld.
-0,15%-2,27%+6,45%-0,06%+2,64%+4,42%-11,95%-8,18%+60,73% 10,21 mld.
-2,93%-4,56%+0,95%+16,55%-14,37%-18,72%-27,17%-19,53%+167,77% 9,9 mld.
+0,15%+3,00%+3,63%+13,55%-0,16%-7,54%-17,22%-22,37%+139,89% 9,06 mld.
+1,07%-15,65%+6,80%+29,53%+1.294,97%+1.069,98%+1.254,89%+316,34%+491,22% 8,22 mld.
+0,14%-.--%-.--%-.--%+48,43%+34,13%+164,58%+25,13%+445,32% 8,38 mld.
+0,62%+1,18%-9,40%-1,48%+13,66%+6,57%-32,60%-34,75% - 6,88 mld.
+1,50%+46,17%+23,69%+26,48%+12.392,31%+11.240,78%+2.008,27% - - 7,91 mld.
-.--%-.--% - - - - - - - 6,07 mld.
Gemiddelde -0,45%+0,57%+5,11%+15,79%+752,44%+670,74%+215,79%+40,90%+275,84% 15,68 mld.
Gewogen gemiddelde per kap. -0,52%-0,67%+4,81%+12,65%+386,81%+343,76%+127,80%+37,54%+257,50%
Biotechnologie & Medisch Onderzoek - Andere
  1. Beurs
  2. Aandelen
  3. Koers SLN
  4. Sector Silence Therapeutics plc